top of page

FDA-approved Kybella™, a non-surgical, safe and effective option to get rid of submental fullness -

better known as a “double chin.”

Benefits of Kybella Treatment for Double Chins or Neck Fat

  • Helps eliminates double chin or neck fat

  • No surgery, no downtime

  • Treatments only take 15-20 minutes

  • Made of a naturally-occurring molecule in the body that aids in the breakdown and absorption of fat

What causes a double chin?

There are three main causes: weight gain, genetics and aging. You definitely don’t have to be overweight to have fullness under your chin. Unfortunately, sometimes, no matter how much you exercise or diet, your double chin may not go away, causing you to look heavier and older than you actually are.​

Who is a candidate for Kybella Injectable Treatment?

Kybella is an ideal treatment for anyone who wants to eliminate fatty areas on the neck and chin. This treatment is the ideal way to reduce your double chin and saggy neck for those who prefer not to do Neck Smartlipo. If you are looking to get more definition in your chin, jawline and neck then Kybella is for you!

How Does Kybella Work?

Kybella is a synthetic formulation of deoxycholic acid – a substance that naturally occurs in your body. This substance, when synthesized, is used to break down and absorb dietary fat. For over 9 years, Kybella has been under development and has been the subject of over 20 clinical studies involving more than 2,600 patients.

When properly injected in the submental area, Kybella has been shown to dissolve the fat that causes double chin. The result – a more streamlined neck and enhanced contour along the jaw line. 


How Long Does the Kybella Treatment Take?

Unlike surgery to remove a double chin or neck fat, Kybella injectable treatment requires only a short office visit. Typically this treatment only takes 15-20 minutes. Treatment length is similar to other injectable fillers like Botox and Juvederm.

What is the downtime with Kybella injections?

While you may experience some bruising and/or swelling at the injection site, there is typically no downtime associated with Kybella injectable treatment. Slight swelling can last between 4 and 7 days.



KYBELLA® is contraindicated in the presence of infection at the injection sites.


Marginal Mandibular Nerve Injury

Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve. Dysphagia

Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition. Injection-Site Hematoma/Bruising

In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur. Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures

To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.


The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Please see KYBELLA® full prescribing information.

Reference: 1. KYBELLA® Prescribing Information, April 2015.

bottom of page